Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues

Digestive Diseases

Volumn 25, Issue 3, 2007, Pages 241-244

  Cuomo, Rosario ^a   Savarese, Maria Flavia ^a   Gargano, Rosalba ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Functional bowel disorders; Irritable bowel syndrome; Post infectious irritable bowel syndrome; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ACUTE GASTROENTERITIS; CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; INFECTION PREVENTION; INFLAMMATORY INFILTRATE; INTESTINE MUCOSA; IRRITABLE COLON; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ARTICLE; CONSENSUS; GASTROENTERITIS;

CONSENSUS; GASTROENTERITIS; HUMANS; IRRITABLE BOWEL SYNDROME; PROBIOTICS; RISK FACTORS;

EID: 35448956122     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103893     Document Type: Conference Paper

References (29)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
2. Talley NJ: Irritable bowel syndrome. Intern Med J 2006;36:724-728.
3. Stewart GT: Post-dysenteric colitis. Br Med J 1950;1:405-409.
4. Chaudhary NA, Truelove SC: The irritable colon syndrome. QJM 1962;123:307-322.
5. Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR: Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003;98:1970-1975.
6. Wang LH, Fang XC, Pan GZ: Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004;53:1096-1101.
7. Halvorson HA, Schlett CD, Riddle MS: Postinfectious irritable bowel syndrome - a meta-analysis. Am J Gastroenterol 2006;101:1894-1899.
8. Spiller RC: Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-1671.
9. Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997;314:779-782.
10. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW: The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-406.
11. Gonsalkorale WM, Perrey C, Pravica V, et al: Interleukin-10 genotypes in irritable bowel syndrome: Evidence for an inflammatory component? Gut 2003;52:91-93.
12. Sarnelli G, Grosso M, De Giorgi F, Petruzzelli R, Atteo E, Cirillo C, Gargano R, Izzo P, Cuomo R: Association between inducibile nitric oxide synthase genetic polymorphisms and postinfectious dyspepsia: a preliminary report. Neurogastroenterol Motil 2006;18:773, A219.
13. Spiller RC, Jenkins D, Thornley JP, et al: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-811.
14. Gwee KA, Collins SM, Read NW, et al: Increased rectal mucosal expression of interleukin-1β in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523-526.
15. Dunlop SP, Jenkins D, Spiller RC: Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-1583.
16. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R: Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005;17:863-870.
17. Barbara G, Vallance BA, Collins SM: Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997;113:1224-1232.
18. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y: The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-563.
19. Collins SM, Valiance B, Barbara G, Borgaonkar M: Putative inflammatory and immunological mechanisms in functional bowel disorders. Baillieres Best Pract Res Clin Gastroenterol 1999;13:429-436.
20. Chadwick VS, Chen W, Shu D, et al: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-1783.
21. Barbara G, Stanghellini V, De Giorgio R, et al: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
22. Camilleri M: Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 2006;40:264-269.
23. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T: Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol 2001;280:G368-G380.
24. Resta-Lenert S, Barrett KE: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli . Gut 2003;52:988-997.
25. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006;55:182-190.
26. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ: Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002;47:2625-2634.
27. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R: Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005;100:1-9.
28. Kim HJ, Camilleri M, McKinzie S, et al: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895-904.
29. O'Mahony L, McCarthy J, Kelly P, et al: Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-551.